Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the...

  • Main
  • 2019 / 7
  • Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the...
Targeted Oncology 2019 / 7

Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib

Kuo, Chih-Hsi Scott, Huang, Chi-Hsien, Liu, Chien-Ying, Pavlidis, Stelios, Ko, Ho-Wen, Chung, Fu-Tsai, Lin, Tin-Yu, Wang, Chih-Liang, Guo, Yi-Ke, Yang, Cheng-Ta
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Targeted Oncology
DOI:
10.1007/s11523-019-00657-1
Date:
July, 2019
File:
PDF, 1.82 MB
english, 2019
Conversion to is in progress
Conversion to is failed